Stay updated on Dupilumab for AKC: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.

Latest updates to the Dupilumab for AKC: Efficacy Study Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a Locations section listing study sites by state (CA, CO, FL, KS, MA, MI, MO, NY, NC, ND, PA, TN, TX, WA) and updated the page revision from v3.3.2 to v3.3.3. The previous state-specific location sections were removed.SummaryDifference1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed, reflecting a minor page revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedRemoved the notice about a lapse in government funding and potential delays in information updates; it also directed users to cc.nih.gov and opm.gov for current operating status.SummaryDifference0.3%

- Check68 days agoChange DetectedThe new screenshot shows changes to study sites (additions and withdrawals) and updated enrollment status, with several locations now listed as Recruiting or Completed.SummaryDifference0.4%

- Check97 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check104 days agoChange DetectedUpdate: revision updated from v3.0.2 to v3.1.0 and a new contact phone number 978-332-9417 added.SummaryDifference0.1%

Stay in the know with updates to Dupilumab for AKC: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.